Cloning and Characterization of Mefloquine-Resistant Plasmodium Falciparum from Thailand

H. Kyle Webster
Search for other papers by H. Kyle Webster in
Current site
Google Scholar
PubMed
Close
,
S. ThaithongChulalongkorn University, Bangkok, Thailand

Search for other papers by S. Thaithong in
Current site
Google Scholar
PubMed
Close
,
K. Pavanand
Search for other papers by K. Pavanand in
Current site
Google Scholar
PubMed
Close
,
K. Yongvanitchit
Search for other papers by K. Yongvanitchit in
Current site
Google Scholar
PubMed
Close
,
C. PinswasdiChulalongkorn University, Bangkok, Thailand

Search for other papers by C. Pinswasdi in
Current site
Google Scholar
PubMed
Close
, and
E. F. Boudreau
Search for other papers by E. F. Boudreau in
Current site
Google Scholar
PubMed
Close
Restricted access

Resistance to mefloquine in Plasmodium falciparum has begun to occur along the border of Thailand and Kampuchea. As a means of assessing the natural occurrence of mefloquine resistance, the admission and post-treatment parasite isolates from a mefloquine treatment failure were cloned and characterized. Clones from the admission isolate were susceptible to mefloquine in vitro (ID50 of 3.4 [2–5], G [95% CI] ng/ml) and showed a mixture of isozyme types for glucose phosphate isomerase (GPI types I and II). The post-treatment clones were resistant to mefloquine in vitro (ID50 of 17.3 [13–23] ng/ml) with only one isozyme (GPI type I) detected. These observations suggest that under mefloquine pressure a resistant parasite population was selected in the patient, indicating that the potential for mefloquine resistance already exists in the indigenous P. falciparum gene pool. In addition, the mefloquine-resistant clones showed decreased susceptibility in vitro to halofantrine suggesting possible cross-resistance to this new antimalarial drug currently under development.

Save